TomasGeraldNeilanMD

Cardiology • Boston, MA

Adult Congenital Heart Disease

Assistant Professor, Medicine-Massachusetts General Hospital, Harvard Med Sch

Join to view full profile

Dr. Neilan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Neilan's full profile

Already have an account?

Office
101 Nicolls Rd
Boston, MA 11794
Phone+1 617-724-2700

Education & Training

Massachusetts General HospitalFellowship, Cardiovascular Disease, 2008 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2008
Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 1999
University College of Dublin National Univ SOMClass of 1996

Certifications & Licensure

MA State Medical License 2008 - 2026
FL State Medical License 2016 - 2018
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Cardiac Fibrosis by CMR in Patients With Cancer Start of enrollment: 2013 Mar 01
Withdrawn
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) Start of enrollment: 2017 Jan 13
Completed
Phase 2
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. Start of enrollment: 2018 Feb 27
Terminated
Phase 2

Publications & Presentations

PubMed

Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors.
Cho-Han Chiang, Junmin Song, Kuan-Yu Chi, Yu-Cheng Chang, Nutchapon Xanthavanij
European Journal of Cancer. 2024-12-11
2 citations
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes ...
Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu
Journal of Clinical Oncology. 2024-12-10
Immune responses in checkpoint myocarditis across heart, blood and tumour.
Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh
Nature. 2024-12-01

Journal Articles

Focus Issue: Imaging in Cardio-Oncology Original Research Anthracycline Therapy Is Associated with Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
Tomas G Neilan, Ravi Shah, ScienceDirect
Myocardial Tissue Remodeling After Orthotopic Heart Transplantation: A Pilot Cardiac Magnetic Resonance Study
Tomas G Neilan, Venkatesh L Murthy, Ravi Shah, Jose Garcia, The International Journal of Cardiovascular Imaging

Press Mentions

Study Reveals How Cancer Immunotherapy Leads to Deadly Form of Heart Inflammation in Some PatientsNovember 6th, 2024
Mechanisms Behind Myocarditis in Cancer Patients Treated with Immune Checkpoint Inhibitors FoundNovember 6th, 2024
Breast Cancer Deaths Lower with Statin Therapy, Taiwanese Data HintApril 26th, 2023
Join now to see all